PACT Awarded US Patent for Thermo Shield™ Fire Suppressant Shipping Wrap

PACT, LLC, an innovator of packaging and crating technologies, has been granted a US patent for its Thermo Shield, a paper-based, fire-resistant shipping wrapdesigned to prevent catastrophes caused by battery explosions during transport. Utilizing a revolutionary technology that actively and automatically cools the internal environment of a corrugated container, the paper-based, 100% recyclable protective logistics product prevents damage to the outside shipping container, suppresses fumes or gasses from escaping, and limits external oxygen supply.

Thermo Shield comprises a lightweight pleated material with a non-toxic moisture vapor application that ensures the safety of lithium-ion products in transport. The solution can suppress thermal runaway and propagation at temperatures up to 800°C, and restrict the temperature outside the wrap itself to 60°C.

Importantly considering the push for sustainable packing solutions, the pleated paper is an eco-friendly material that protects the environment even while shielding items from hazardous thermal runaway events, including fires.

The solution’s credentials are a step up from competitors: Thermo Shield is a paper-based wrap solution that exceeds the proposed SAE G27 lithium battery packaging performance standards for safety in shipping.The shipper also is lightweight and reusable, lending to cost efficiency both at initial purchase and during use.

The urgent industry need to mitigate dangerous thermal runaway events makes Thermo Shield a potentially groundbreakingsolution, one capable of drastically limiting the amount of thermal runaway to protect both logistics personnel and valuable cargo.Per the United Parcel Service (UPS), just seven of their customers are responsible for shipping over 40 million lithium-ion batteries per year. Further, the majority of cells or battery packs are produced in Asia, leading to long transit times when shipping to the Western Hemisphere.

Thermo Shield’s one-of-a-kind design allows it to suppress serious thermal runaway incidents, protecting freight transporters and the cargo they’re tasked with delivering,” said Rodger Mort, President of PACT, LLC. “Being recognized with a US patent serves as validation that Thermo Shield™ not only works, but does so in a novel, unique fashion.”

More here.

SourcePact LLC

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.